SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

Stifel Downgrades Inovio Pharmaceuticals to Hold, Raises Price Target to $24

Stifel analyst Stephen Willey downgrades Inovio Pharmaceuticals (NASDAQ:INO) from Buy to Hold and raises the price target from $19 to $24.

Benzinga · -
Stifel analyst Stephen Willey downgrades Inovio Pharmaceuticals (NASDAQ: INO) from Buy to Hold and raises the price target from $19 to $24.